12:00 AM
 | 
Feb 08, 2016
 |  BC Week In Review  |  Company News  |  Deals

Alere, Abbott deal

Abbott will acquire diagnostics company Alere for $56 per share in cash, or about $5.8 billion. The price is a 50.5% premium to Alere’s close of $37.20 on Jan....

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >